NEW PRODUCT
Tesamorelin

GHRH Peptide Therapy

Tesamorelin is a synthetic form of growth hormone-releasing hormone (GHRH). It is the active ingredient in Egrifta, an FDA-approved medication used to reduce excess abdominal fat in a specific group of patients. At It’s A Secret Med Spa, tesamorelin is prescribed by a licensed provider as part of a supervised wellness plan and prepared by a licensed compounding pharmacy. Compounded tesamorelin is not FDA-approved.

Get Started Today for a Healthier, More Vibrant You

Tesamorelin peptide therapy at It's A Secret Med Spa

What Is Tesamorelin?

Tesamorelin is a 44-amino-acid peptide that mimics your body’s natural GHRH and prompts the pituitary gland to release its own growth hormone. In clinical studies of the branded product (Egrifta) in adults with HIV-associated excess abdominal fat, it reduced visceral fat over 26 to 52 weeks of daily use. It has not been evaluated by the FDA for general weight loss or body contouring. Your provider will discuss whether it fits your goals and health history.

Tesamorelin (Synthetic GHRH)

Function: Stimulates the pituitary gland to release growth hormone in its natural pulses.

Benefit: Works with your body’s own hormone signaling rather than replacing growth hormone.

How It Is Used

Function: Prescribed by a licensed provider after a consultation and a review of your health history. Dosing is individualized.

Benefit: Ongoing provider monitoring, with follow-up visits to review how you are responding and adjust your plan.

Why Tesamorelin?

Patients and providers often choose tesamorelin because it:

  • Is the active ingredient of an FDA-approved medication, with published clinical studies

  • Supports the body’s own growth hormone release
  • Is prescribed and monitored by a licensed provider

Key Benefits

Natural GH Support
Prompts the pituitary gland to release its own growth hormone
Studied Ingredient
Active ingredient of Egrifta, an FDA-approved medication
Provider Guided
Prescribed and monitored by a licensed provider
Daily Routine
A small injection under the skin, once daily
Individual Plan
Dosing and duration are set by your provider
Natural GH Support
Prompts the pituitary gland to release its own growth hormone
Studied Ingredient
Active ingredient of Egrifta, an FDA-approved medication
Provider Guided
Prescribed and monitored by a licensed provider
Daily Routine
A small injection under the skin, once daily
Individual Plan
Dosing and duration are set by your provider

What to Expect

Response to tesamorelin varies from person to person. In clinical studies of the branded product, changes in abdominal fat were measured over 26 to 52 weeks of daily use, and the effect reversed after stopping. Your provider will review your progress at follow-up visits and adjust your plan as needed. Individual results vary.

Tesamorelin is prescribed and monitored by a licensed provider

How It Works

Safety Information:
Side Effects & Risks

Tesamorelin is generally well tolerated, but potential side effects can include:

  • Injection site reactions, such as redness, itching, pain, bruising, or swelling.
  • Joint pain, muscle pain, or swelling in the hands and feet.
  • Numbness or tingling.
  • Raised blood sugar, which can be a concern for people with diabetes or prediabetes.
  • Headache or nausea.

Tesamorelin should not be used during pregnancy, by anyone with active cancer, or by anyone with a condition affecting the pituitary gland, and it is not appropriate for everyone. Tell your provider about all medical conditions and medications. Tesamorelin is prescribed only after provider evaluation.

Medication is only issued after provider evaluation and only if clinically appropriate. Compounded medications are prepared by a licensed 503A pharmacy and are not FDA-approved.

Other Peptides

MOTS-c

Learn More

Melanotan II

Learn More

KLOW

Learn More